Theramex

NICE recommends Yselty▼ (linzagolix) for symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis

1 May 2025 -- London, UK -- Theramex is pleased to announce that the National Institute for Health and Care Excellence (NICE) has recommended NHS reimbursement of the extended indication for Yselty (linzagolix) for the symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis. It is...
5th Floor, 50 Broadway, London, SW1H 0BL, UK

020 3962 5555